Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Craig Seaman
With
Vascular Medicine Institute
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of ACS defined as a new pulmonary infiltrate involving at least one segment of the lung on a chest x-ray or chest CT scan with 2 or more of the following: chest pain, tachypnea, dyspnea, cough, hypoxemia, or body temperature greater than or equal to 38.0 degrees Celsius
Hemoglobin electrophoresis confirming HbSS, SC, or B0 (historical records sufficient)
Age greater than or equal to 18
You may not be if
Any absolute contraindication to heparin
Platelet count less than 50 per microliter (current admission)
Historical diagnosis of moyamoya disease as documented in medical records
Historical diagnosis of proliferative retinopathy as documented in medical records
Current participation in a chronic exchange transfusion program
Underlying hypercoagulable disorder other than sickle cell disease
Currently receiving therappeutic anticoagulation
Currently receiving antiplatelet agents
Currently receiving estrogen containing oral contraceptives
Chest CT scan documented PE performed as standard of care prior to study enrollment (current admission)
Clareo Health | Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
